PI11237 2-Azabicyclo[2.2.1]Hept-5-En-3-One (CAS No.: 49805-30-3)

2-Azabicyclo[2.2.1]Hept-5-En-3-One (CAS No.: 49805-30-3) Description

2-Azabicyclo[2.2.1]Hept-5-En-3-One is a heterocyclic compound with the chemical formula C6H7NO. It is incorporated into synthetic pathways for active pharmaceutical ingredients. Its molecular architecture, featuring an amine and a ketone group within a rigid bicyclic framework, is critical for subsequent functional group transformations. The compound's well-defined reactivity supports its integration into controlled synthetic environments.

2-Azabicyclo[2.2.1]Hept-5-En-3-One (CAS No.: 49805-30-3) Applications

Pharmaceutical Manufacturing
- Used as an intermediate in the synthesis of drug molecules to streamline alkylation steps by exploiting its bicyclic framework, thereby refining reaction selectivity.

Organic Synthesis Research
- Employed as a building block in heterocycle formation to facilitate scaffold development with predictable reactivity, supporting laboratory-scale process optimisation.

Chemical Process Development
- Applied in reagent studies to assess reaction kinetics and scalability, assisting in the development of reliable batch processing protocols.

2-Azabicyclo[2.2.1]Hept-5-En-3-One (CAS No.: 49805-30-3) Packing

2-Azabicyclo[2.2.1]Hept-5-En-3-One is packaged in sealed, moisture-resistant containers with inner anti-static liners to reduce dust and contamination. The packaging design includes temperature-controlled barriers to mitigate exposure to environmental humidity. Customised packaging options, including unit dosing and specific labelling, are available to meet laboratory and industrial requirements while ensuring product integrity throughout transport and storage.

Additional Information

Chemical intermediates such as 2-Azabicyclo[2.2.1]Hept-5-En-3-One play a significant role in modern pharmaceutical synthesis. Their defined molecular structures enable targeted reactions, which are essential for constructing complex drug candidates. Understanding the reactivity patterns and stability of such compounds can lead to more efficient synthesis routes and optimised process design.

In the broader context of organic synthesis, bicyclic compounds with integrated functional groups offer versatility in forming diverse chemical architectures. Detailed knowledge of these intermediates assists in refining reaction conditions, scaling processes, and reducing by-product formation, thereby supporting advancements in pharmaceutical development.